Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

¿Afecta la estenosis cervical la función de la mano?

2 de noviembre de 2026 actualizado por: Kadir Songur, Izmir Democracy University

¿Afecta el grado de estenosis espinal cervical a la función de la mano?

The cervical spine is a complex structure that supports the weight of the head and protects the spinal cord and nerve roots. Cervical spinal stenosis (CSS), which develops as a result of degenerative processes, can cause narrowing of the spinal canal and compression of nerve structures, leading to symptoms such as pain, numbness, and weakness. This condition can negatively affect hand function, particularly grip strength and dexterity. However, studies in the literature examining the effect of CSS on grip strength and hand function are limited. Therefore, this study will be conducted to determine the effect of the severity of cervical spinal stenosis, identified in patients who underwent MRI following their presentation with cervical problems at the Physical Medicine and Rehabilitation outpatient clinic of Buca Seyfi Demirsoy Training and Research Hospital, İzmir Democracy University, on hand grip strength and functionality. Grip strength will be assessed using the Jamar hand dynamometer, and fine pinch strength will be evaluated using the Lafayette pinch meter. Additionally, hand functionality will be measured using the Nine-Hole Peg Test. The impact of neck pain on daily life will be assessed using the Neck Disability Index. The data obtained will be compared and analyzed using appropriate statistical methods.

This study is expected to fill a significant gap in the current literature by comprehensively elucidating the effects of cervical stenosis on hand function and grip performance, thereby contributing to the individualization of rehabilitation approaches.

Descripción general del estudio

Tipo de estudio

De observación

Inscripción (Actual)

186

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The sample for this study will consist of individuals who presented to the Physical Medicine and Rehabilitation outpatient clinic at the Buca Seyfi Demirsoy Training and Research Hospital of Izmir Democracy University due to cervical problems and underwent cervical MRI. After obtaining informed consent, the individuals included in the study will undergo evaluation. First, participants will be grouped based on their cervical stenosis scores. The degree of cervical stenosis will be determined using MRIs that were previously requested and performed during various outpatient services. The evaluation of the MRI will be scored according to the Kang grading system for spinal stenosis. The Kang grading system includes four degrees ranging from 0 to 3 based on spinal cord compression.

Descripción

Inclusion Criteria:

  • Individuals aged 18-75
  • Individuals who have previously undergone a cervical MRI
  • Cases where the degree of stenosis can be clearly determined on MRI
  • Individuals who have had neck pain for at least 3 months

Exclusion Criteria:

  • Individuals who declined to participate in the study
  • Individuals who had undergone cervical surgery
  • Individuals diagnosed with vertigo
  • Individuals with sudden hearing loss
  • Individuals with additional neurological conditions
  • Individuals with psychiatric or cognitive disorders that would prevent measurement in the study

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: CASE_ONLY
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
1

Group with Kang grade 0

2

Group with Kang grade 1

3

Group with Kang grade 2

4

Group with Kang grade 3

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Hand Grip Strength
Periodo de tiempo: Day 1

Hand grip strength will be assessed using a Jamar hydraulic hand dynamometer. Measurements will be taken while seated, with the arm positioned as follows: shoulder adduction, elbow at 90° flexion, and forearm in a neutral position. The wrist will be positioned at 0-30° extension and 0-15° ulnar deviation. The volunteer will be asked to grip the dynamometer firmly and squeeze as hard as possible. The measurements will be repeated three times, and the average value will be recorded in kilograms.

Day 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pinch Strength
Periodo de tiempo: Day 1

A Lafayette brand hydraulic pinch meter will be used for this measurement. Measurements will be taken in three ways: two-point, lateral, and three-point grips. For the two-point grip measurement, the subject will be asked to squeeze the pinch meter using the tips of their thumb and index finger. For the lateral grip measurement, the volunteer will be asked to squeeze the pinch meter using the middle of the distal phalanx of the thumb and the lateral part of the middle phalanx of the index finger. For the three-point grip measurement, the subject will be instructed to squeeze the pinch meter using the distal phalanges of the thumb, index finger, and middle finger. Measurements will be taken in the same position as the grip strength test, in accordance with the standard; three measurements will be taken for each grip type, and the average will be recorded in pounds (lb).

Day 1
The Nine-Hole Peg Test
Periodo de tiempo: Day 1

The participants' manual dexterity will be assessed using the Nine-Hole Peg Test, which has been proven to be valid and reliable. The test consists of nine identical holes spaced at equal intervals and nine matching pegs. The timer starts the moment the person first touches a peg to place it. The person will be asked to take the pegs from the box, place them in the holes as quickly as possible, and then remove them and return them to the box. The test will be conducted while the person is seated. The activity time will be recorded in seconds.

Day 1
Neck Disability Index
Periodo de tiempo: Day 1

The Neck Disability Index is an adaptation of the Oswestry Disability Index for the cervical region and is a widely used 10-item questionnaire for assessing cervical dysfunction and neck pain. Each item is scored between 0 (no disability) and 5 (complete disability). The total score ranges from 0 to 50; a higher score indicates greater functional limitation. The questionnaire has established validity and reliability in Turkish.

Day 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de agosto de 2026

Finalización primaria (Actual)

1 de octubre de 2026

Finalización del estudio (Actual)

1 de noviembre de 2026

Fechas de registro del estudio

Enviado por primera vez

30 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de marzo de 2026

Publicado por primera vez (Actual)

6 de abril de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

4 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de noviembre de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data (IPD) will not be shared because the data contain potentially identifiable sensitive clinical information, and sharing was not covered in the original informed consent provided to participants. Additionally, institutional and national data protection regulations limit the transfer of raw, de-identified individual-level data outside the research team.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir